Announcements Trials
Browse Landscape

Status

Completed 1126Unknown 787Recruiting 523Terminated 200Active not recruiting 160Not yet recruiting 158Withdrawn 58Enrolling by invitation 20Suspended 13Available 3Approved for marketing 2No longer available 1

Sponsor Class

INDUSTRY 1

Study Type

Expanded_access 1

Sponsor

Cancer Type

Sarcoma 1Gynecologic 1Gastrointestinal 1

Conditions

Pancreatic Neoplasms 5Gastrointestinal Stromal Tumors 5Colorectal Neoplasms 5Carcinoma, Hepatocellular 5Liver Neoplasms 4Ovarian Neoplasms 2Melanoma 2Cholangiocarcinoma 2Wilms Tumor 1Uveal Melanoma 1Uterine Neoplasms 1Stomach Neoplasms 1Sarcoma, Ewing 1Rhabdomyosarcoma 1Rhabdoid Tumor 1Retinoblastoma 1Prostatic Neoplasms 1Pinealoma 1Neuroectodermal Tumors, Primitive 1Neuroblastoma 1Neoplasms 1Neoplasm Metastasis 1Meningeal Neoplasms 1Medulloblastoma 1Liver Diseases 1Liver Cirrhosis 1Klatskin Tumor 1Hepatoblastoma 1Hepatitis D 1Hepatitis B 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
No longer available × Stomach Neoplasms × Gastrointestinal × Clear all
NCT04681248 2025-08-03

Expanded Access Use of DKN-01 for the Treatment of Advanced Solid Tumors

Leap Therapeutics, Inc.

No longer available
GastrointestinalGynecologicSarcoma

Carcinoma, Squamous Cell, Carcinosarcoma, Esophageal Neoplasms, Ovarian Neoplasms, Stomach Neoplasms, Uterine Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡